亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Prognostic Impact of Postoperative Lymph Node Metastases After Neoadjuvant Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of Esophagus: From the Results of NEOCRTEC5010, a Randomized Multicenter Study.

新辅助治疗 放化疗 食管切除术 存活率 阶段(地层学) 食管癌 淋巴血管侵犯 放射治疗 食管鳞状细胞癌 淋巴 倾向得分匹配 回顾性队列研究 放射科 比例危险模型 外科
作者
Xuefeng Leng,Wenwu He,Hong Yang,Yuping Chen,Chengchu Zhu,Wentao Fang,Zhentao Yu,Weimin Mao,Jiaqing Xiang,Zhijian Chen,Haihua Yang,Jiaming Wang,Qingsong Pang,Xiao Zheng,Hui Liu,H. Yang,Tao Li,Xu Zhang,Qun Li,Geng Wang,Teng Mao,Xufeng Guo,Ting Lin,Mengzhong Liu,Jianhua Fu,Yongtao Han
出处
期刊:Annals of Surgery [Lippincott Williams & Wilkins]
卷期号:274 (6) 被引量:21
标识
DOI:10.1097/sla.0000000000003727
摘要

Objective To determine the prognostic impact of pathologic lymph node (LN) status and investigate risk factors of recurrence in esophageal squamous cell carcinoma (ESCC) patients with pathologic complete response (pCR) after neoadjuvant chemoradiotherapy (NCRT). Summary background data There are no large-scale prospective study data regarding ypN status and recurrence after pCR in ESCC patients receiving NCRT. Methods The NEOCRTEC5010 trial was a prospective multicenter trial that compared the survival and safety of NCRT plus surgery (S) with S in patients with locally advanced ESCC. The relationships between survival and cN, pN, and ypN status were assessed. Potential prognostic factors in patients with ypN+ and pCR were identified. Results A total of 389 ESCC patients (NCRT: 182; S: 207) were included. Patients with pN+ in the S group and ypN+ in the NCRT group had decreased overall survival (OS) and disease-free survival (DFS) compared with pN0 and ypN0 patients, respectively. Partial response at the primary site [hazard ratio (HR), 2.09] and stable disease in the LNs (HR, 3.26) were independent risk factors for lower DFS, but not OS. For patients with pCR, the recurrence rate was 13.9%. Patients with distant LN metastasis had a median OS and DFS of 16.1 months and 14.4 months, respectively. Failure to achieve the median total dose of chemotherapy was a significant risk factor of recurrence and metastasis after pCR (HR, 44.27). Conclusions Persistent pathologic LN metastasis after NCRT is a strong poor prognostic factor in ESCC. Additionally, pCR does not guarantee a cure; patients with pCR should undergo an active strategy of surveillance and adjuvant therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
3秒前
11秒前
21秒前
朴实云应发布了新的文献求助10
27秒前
林子青完成签到,获得积分10
1分钟前
核桃发布了新的文献求助30
1分钟前
李健应助reerwt采纳,获得10
1分钟前
1分钟前
ICSSCI发布了新的文献求助10
1分钟前
1分钟前
刘宇童给刘宇童的求助进行了留言
1分钟前
reerwt发布了新的文献求助10
1分钟前
1分钟前
科研通AI2S应助科研通管家采纳,获得10
1分钟前
科研通AI2S应助科研通管家采纳,获得10
1分钟前
ICSSCI完成签到,获得积分10
2分钟前
2分钟前
董可以发布了新的文献求助10
2分钟前
风华正茂完成签到,获得积分10
2分钟前
2分钟前
3分钟前
jimmy_bytheway完成签到,获得积分0
3分钟前
桃桃发布了新的文献求助10
3分钟前
可爱的函函应助桃桃采纳,获得10
3分钟前
3分钟前
3分钟前
3分钟前
3分钟前
NexusExplorer应助科研通管家采纳,获得10
3分钟前
所所应助爱笑的毛衣采纳,获得10
3分钟前
4分钟前
4分钟前
duan完成签到 ,获得积分10
4分钟前
holder完成签到,获得积分10
4分钟前
4分钟前
沐白发布了新的文献求助10
4分钟前
4分钟前
刘宇童发布了新的文献求助10
5分钟前
大模型应助吕易巧采纳,获得10
5分钟前
迷人问兰完成签到,获得积分10
5分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990049
求助须知:如何正确求助?哪些是违规求助? 3532108
关于积分的说明 11256369
捐赠科研通 3270998
什么是DOI,文献DOI怎么找? 1805166
邀请新用户注册赠送积分活动 882270
科研通“疑难数据库(出版商)”最低求助积分说明 809228